Enzymotec Ltd. to Participate in the Canaccord Genuity 34th Annual Growth Conference

MIGDAL HA'EMEQ, Israel, July 31, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today that Dr. Ariel Katz, President and Chief Executive Officer, and Oren Bryan, Vice President and Chief Financial Officer, will present at the Canaccord Genuity 34th Annual Growth Conference on Thursday, August 14, 2014 at 8:30 a.m. ET in Boston, MA.

The audio portion of Enzymotec's presentation will be webcast live, and a replay will be available on the Investors section of the Company's website at www.enzymotec.com.

About Enzymotec Ltd.

Enzymotec Ltd. is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio- active lipid ingredients, as well as final products, based on sophisticated processes and technologies. For more information, visit www.enzymotec.com.

CONTACT: ICR Katie Turner 646-277-1228 Katie.Turner@icrinc.com John Mills 310-954-1105 John.Mills@icrinc.comSource:Enzymotec Ltd.